Kestra Medical Technologies, Ltd.
$20.69
The Read: KMTS stock has historically moved about 25% on earnings, as seen in March 2026 when meeting EPS estimates failed to offset investor concerns over persistent net losses, while positive clinical data presentations have driven smaller 12% gains.
Price
Overlays
Panel
KMTS
Hover to view data
No Data